The Lancet Haematology in conversation with
合計時間：
11 h 01 min
Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma
The Lancet Haematology in conversation with
15:49
Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia
The Lancet Haematology in conversation with
17:47
Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
The Lancet Haematology in conversation with
27:06
Dawn Swan on air pollution and venous thromboembolism
The Lancet Haematology in conversation with
15:02
Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis
The Lancet Haematology in conversation with
16:03
Neema Mayor and Caitlin Farrow on impact of patient ethnicity on haematopoeietic cell transplantation outcome in the United Kingdom
The Lancet Haematology in conversation with
17:53
Lancet Haematology 10 year anniversary - meet the editors
The Lancet Haematology in conversation with
47:21
Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome
The Lancet Haematology in conversation with
08:08
Kim Linton on follicular lymphoma
The Lancet Haematology in conversation with
09:48
Judy Truong on ferritin reference levels and iron deficiency
The Lancet Haematology in conversation with
11:17
Johannes Schetelig on remission induction versus immediate allogeneic HSCT for patients with AML
The Lancet Haematology in conversation with
14:11
Banu Aygun on sickle cell anaemia
The Lancet Haematology in conversation with
11:13
Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia
The Lancet Haematology in conversation with
18:06
Elisabeth Schorb on the MARTA phase 2 trial
The Lancet Haematology in conversation with
09:23
Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies
The Lancet Haematology in conversation with
13:03
Dr Sarah O'Brien on the PREVAPIX-ALL trial
The Lancet Haematology in conversation with
13:50
Enrico Lopriore on haemolytic disease of the fetus and newborn
The Lancet Haematology in conversation with
12:33
Meletios Dimopoulos on relapsed and refractory multiple myeloma
The Lancet Haematology in conversation with
11:00
Eric Ohuma on haemoglobin concentrations and neonatal outcomes
The Lancet Haematology in conversation with
16:27
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding
The Lancet Haematology in conversation with
13:13
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma
The Lancet Haematology in conversation with
16:32
Alok Srivastava on fitusiran for patients with haemophilia A and B
The Lancet Haematology in conversation with
18:41
Emmanuela E Ambrose on stroke prevention in children with sickle cell disease
The Lancet Haematology in conversation with
11:31
Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes
The Lancet Haematology in conversation with
22:10
Xiao-Jun Huang on cellular therapy in China
The Lancet Haematology in conversation with
28:10
Glenn Pierce on haemophilia care in LMICs
The Lancet Haematology in conversation with
34:55
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders
The Lancet Haematology in conversation with
12:50
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline
The Lancet Haematology in conversation with
15:05
Fredrik Schjesvold on OCEAN phase 3
The Lancet Haematology in conversation with
12:24
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia
The Lancet Haematology in conversation with
11:59
Raul Cordoba on haematological malignancies in older people
The Lancet Haematology in conversation with
16:24
Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria
The Lancet Haematology in conversation with
09:03
Zuguo Mei and Gary Brittenham on iron deficiency
The Lancet Haematology in conversation with
08:34
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care
The Lancet Haematology in conversation with
29:11
Eugenia Trigoso Arjona (in English) on nursing and haematological care
The Lancet Haematology in conversation with
28:34
Nada Hamad on inclusion and diversity in haematology
The Lancet Haematology in conversation with
30:02
Dr Judith Boer on lymphoblastic leukaemia in children
The Lancet Haematology in conversation with
10:24
Imatinib for paediatric leukaemia
The Lancet Haematology in conversation with
08:33
Predicting the risk of adenoviraemia
The Lancet Haematology in conversation with
04:51
Adverse events in haematological malignancies
The Lancet Haematology in conversation with
12:31
